Volume 31, Issue 2 (July 2024)                   J Birjand Univ Med Sci. 2024, 31(2): 140-149 | Back to browse issues page

Research code: 15930554942009
Ethics code: IR.IAU.TON.REC.1398.007


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Tajdar M, Zahmatkesh Roodsari R. Relationship between the TLR5 -1174C>T Polymorphism in Patients with peptic ulcer and Helicobacter pylori infection in Mazandaran province. J Birjand Univ Med Sci. 2024; 31 (2) :140-149
URL: http://journal.bums.ac.ir/article-1-3407-en.html
1- Department of Cell and Molecular Biology, Faculty of Biological Sciences, Tonekabon Branch, Islamic Azad University, Tonkabon, Iran
2- Department of Cell and Molecular Biology, Faculty of Biological Sciences, Tonekabon Branch, Islamic Azad University, Tonkabon, Iran , zahmatkesh.rasoul@gmail.com
Abstract:   (334 Views)
Background and Aims: Peptic ulcer is a painful inflammatory disease occurring inside the gastric or the first part of the small intestine (duodenum). One of the leading causes of this disease is Helicobacter pylori infection. Toll-like receptors (TLRs) play a crucial role as a warning factor in the detection of Helicobacter pylori infection in the immune system. TLRs belong to a group of pattern recognition receptors of the host's innate immune system. The present study aimed to assess the relationship between the C1174T polymorphism of the TLR5 gene and Helicobacter pylori infection in patients with peptic ulcers in Mazandaran province.
Materials and Methods: This case-control study investigated 150 patients with peptic ulcer and Helicobacter pylori infection and 150 healthy individuals. After extracting genomic DNA from gastric biopsy samples, genotypic and allelic frequency in patients and control group was determined by Three primer ARMS PCR method. Data were analyzed in SPSS software (version 23).
Results: The frequency rates of CC, CT, and TT genotypes in patients were 19.3%, 49.3%, and 31.3%, respectively. In healthy people, these values were obtained at 38.6%, 45.3%, and 16%, respectively. Statistical analysis demonstrated a significant relationship between the C1174T polymorphism of the TLR5 gene and peptic ulcer disease.
Conclusion: As evidenced by the results of this study, the presence of the T allele at the C1174T position can be considered a factor for increasing the risk of peptic ulcer disease; nonetheless, the investigation of other TLR5 gene polymorphisms in larger populations is needed.
Full-Text [PDF 444 kb]   (186 Downloads)    
Type of Study: Original Article | Subject: Medical Genetics
Received: 2024/04/4 | Accepted: 2024/06/4 | ePublished ahead of print: 2024/08/7 | ePublished: 2024/08/5

References
1. Ren J, Jin X, Li J, Li R, Gao Y, Jingjing Zhang, et al. The global burden of peptic ulcer disease in 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Int J Epidemiol. 2022; 31(5): 1666-76. DOI: 10.1093/ije/dyac033 [DOI:10.1093/ije/dyac033]
2. Sayehmiri K, Abangah Gh, Kalvandi Gh, Tavan H, Aazami S. Prevalence of peptic ulcer in Iran: Systematic review and meta‑analysis methods. J Res Med Sci. 2018; 23: 8. DOI: 10.4103/jrms.JRMS_1035_16. [DOI:10.4103/jrms.JRMS_1035_16]
3. Tuerk E, Doss S, Polsley K. Peptic ulcer disease. Prim Care. 2023; 50(3): 351-62. DOI: 10.1016/j.pop.2023.03.003 [DOI:10.1016/j.pop.2023.03.003]
4. McConaghy JR, Decker A, Nair S. Peptic Ulcer disease and H. pylori infection: common questions and answers. Am Fam Physician. 2023; 107(2): 165-72. PMID: 36791443
5. Narayanan M, Reddy KM. Marsicano E. Peptic ulcer disease and Helicobacter pylori infection. Mo. Med. 2018; 115(3): 219-24. PMID: 30228726
6. Victor E Reyes. Helicobacter pylori and Its Role in Gastric Cancer. Microorganisms. 2023; 11(5):1312. DOI: 10.3390/microorganisms11051312. [DOI:10.3390/microorganisms11051312]
7. Silvia Salvatori ,Irene Marafini,Federica Laudisi ,Giovanni Monteleone, Carmine Stolfi. Helicobacter pylori and Gastric Cancer: Pathogenetic Mechanisms. Int. J. Mol. Sci. 2023, 24(3), 2895; DOI: 10.3390/ijms24032895 [DOI:10.3390/ijms24032895]
8. Duan T, Yang, Xing Ch, Wang HY, Wang RF. Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity. Front Immunol. 2022; 13: 812774. DOI: 10.3389/fimmu.2022.812774 [DOI:10.3389/fimmu.2022.812774]
9. Pachathundikandi SK, Tegtmeyer N, Backert S. Masking of typical TLR4 and TLR5 ligands modulates inflammation and resolution by Helicobacter pyliri. Trends in microbiology. 2023; 31(9): 903-15. URL: 10.1016/j.tim.2023.03.009 [DOI:10.1016/j.tim.2023.03.009]
10. Meliț LE, Mărginean CO, Mărginean CD, Mărginean MO. The Relationship between Toll-like Receptors and Helicobacter pylori-Related Gastropathies: Still a Controversial Topic. J Immunol Res. 2019; 2019(1): 8197048. DOI: 10.1155/2019/8197048. [DOI:10.1155/2019/8197048]
11. Kim JH, Byeol Namgung, JeonYJ, SongWS, Lee J,Kang SG. Helicobacter pylori flagellin: TLR5 evasion and fusion-based conversion into a TLR5 agonist. Biochem Biophys Res Commun. 2018; 505(3):872-8. DOI: 10.1016/j.bbrc.2018.09.179. [DOI:10.1016/j.bbrc.2018.09.179]
12. Tegtmeyer N, Neddermann M, Lind J, Pachathundikandi SK, Sharafutdinov I, Gutierrez-Escobar AJ, et al. Toll-like Receptor 5 Activation by the CagY Repeat Domains of Helicobacter pylori. Cell Rep. 2020; 32(11): 108159. DOI: celrep.2020.108159 [DOI:10.1016/j.]
13. Pachathundikandi SK, Tegtmeyer N, Arnold IC, Lind J, Neddermann M, Falkeis-Veit C, et al. T4SS-dependent TLR5 activation by Helicobacter pylori infection. Nat Commun. 2019; 10(1): 5717. URL: 10.1038/s41467-019-13506-6 [DOI:10.1038/s41467-019-13506-6]
14. Kurz B, Arndt S, Unger P, Ivanova I, Berneburg M, Hellerbrand C, Karrer S. Association of polymorphous light eruption with NOD-2 and TLR-5 gene polymorphisms. J Eur Acad Dermatol Venereol. 2022; 36(11): 2172-80. DOI: 10.1111/jdv.18364 [DOI:10.1111/jdv.18364]
15. Shuang C, Weiguang Y, Zhenkun F, Yike H, Jiankun Y, Jing X, et al. Toll-like receptor 5 gene polymorphism is associated with breast cancer susceptibility. Oncotarget. 2017; 8(51): 88622-9. DOI: 10.18632/oncotarget.20242 [DOI:10.18632/oncotarget.20242]
16. Alsinnari YM, Alqarni MS, Attar M, Bukhari ZM, Almutairi M, Baabbad FM. Risk Factors for Recurrence of Peptic Ulcer Disease: A Retrospective Study in Tertiary Care Referral Center. Cureus. 2022; 14(2): e22001. DOI: 10.7759/cureus.22001 [DOI:10.7759/cureus.22001]
17. Peiffer S, Pelton M, Keeney L, Kwon EG, Ofosu-Okromah R, Acharya Y, et al. Risk factors of perioperative mortality from complicated peptic ulcer disease in Africa: systematic review and meta-Analysis. BMJ Open Gastro. 2020; 7(1): e000350. DOI:10.1136/bmjgast-2019-000350 [DOI:10.1136/bmjgast-2019-000350]
18. Malik JA, Kaur G, Agrewala JN. Revolutionizing medicine with toll-like receptors: A path to strengthening cellular immunity. Int J Biol Macromol. 2023; 253(7): e127252. DOI: 10.1016/j.ijbiomac.2023.127252 [DOI:10.1016/j.ijbiomac.2023.127252]
19. Yang J, Yan H. TLR5: beyond the recognition of flagellin. Cell Mol Immunol. 2017; 14(12): 1017-9. DOI:10.1038/cmi.2017.122 [DOI:10.1038/cmi.2017.122]
20. Feng S, Zhang C, Chen S, He R, Chao G, Zhang S. TLR5 Signaling in the Regulation of Intestinal Mucosal Immunity. J Inflamm Res. 2023; 16: 2491-501. DOI: 10.2147/JIR.S407521 [DOI:10.2147/JIR.S407521]
21. Jin S, Nepal N, Gao Y. The role of toll-like receptors in peptic ulcer disease Immunol Med. 2022; 45(2): 69-78. DOI: 10.1080/25785826.2021.1963190 [DOI:10.1080/25785826.2021.1963190]
22. Noh J, Yoon S, Don Kim T, Inpyo Choi I,Jung H . Toll-Like Receptors in Natural Killer Cells and Their Application for Immunotherapy. J Immunol Res. 2020; 2020: 2045860. DOI: 10.1155/2020/2045860 [DOI:10.1155/2020/2045860]
23. AL-Eitan L, Almomani FA, Al-Khatib SM, Aljamal HA, Al-Qusami MN, Aljamal RA. Association of toll-like receptor 4, 5 and 10 polymorphisms with Helicobacter pylori- positive peptic ulcer disease in a center in Jordan. Ann Saudi Med. 2021; 41(4): 206-15. DOI: 10.5144/0256-4947.2021.206. [DOI:10.5144/0256-4947.2021.206]
24. Goda V, Jayaraman M, Loganathan R, Nazeer M, Ali M, Karunakaran P. TLR5 Polymorphisms rs2072493, rs5744174, and rs5744168 Are Not Genetic Risk Factors for Chronic Helicobacter pylori Infection in Indian Tamils. Immunol Invest. 2017; 46(6): 537-43. DOI: 10.1080/08820139.2017.1319381 [DOI:10.1080/08820139.2017.1319381]
25. Xu T, Fu D, Ren Y, Dai Y, Lin J, Tang L. Genetic variations of TLR5 gene interacted with Helicobacter pylori infection among carcinogenesis of gastric cancer. Oncotarget. 2017; 8(19): 31016-22. DOI: 10.18632/oncotarget.16050 [DOI:10.18632/oncotarget.16050]
26. Al Othaim A, Al-Hawary SI, Alsaab HO, Almalki SG, Najm MA, Hjazi A, et al. Common variants in toll-like receptor family genes and risk of gastric cancer: a systematic review and meta-analysis. Front Genet. 2023; 14: 1280051. DOI: 10.3389/fgene.2023.1280051 [DOI:10.3389/fgene.2023.1280051]
27. Meena NK, Ahuja V, Meena K, Paul J. Association of TLR5 Gene Polymorphisms in Ulcerative Colitis Patients of North India and Their Role in Cytokine Homeostasis. PLOS One. 2015; 10(3): e0120697. DOI: 10.1371/journal.pone.0120697 [DOI:10.1371/journal.pone.0120697]
28. Törmänen S, Teräsjärvi J, Lauhkonen E, Helminen M, Koponen P, Korppi M, et al. TLR5 rs5744174 gene polymorphism is associated with the virus etiology of infant bronchiolitis but not with post‐ bronchiolitis asthma. Health Sci Rep. 2018; 1(6): e38. DOI: 10.1002/hsr2.38 [DOI:10.1002/hsr2.38]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Journal of Birjand University of Medical Sciences

Designed & Developed by : Yektaweb